Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21750924)

Published in Cell Mol Neurobiol on July 13, 2011

Authors

Sebok Kumar Halder1, Hiroshi Ueda

Author Affiliations

1: Division of Molecular Pharmacology and Neuroscience, Nagasaki University Graduate School of Biomedical Sciences, 1-14 Bunkyo-machi, Nagasaki, 852-8521, Japan.

Articles cited by this

Mechanisms and functional implications of adult neurogenesis. Cell (2008) 14.50

Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci (2005) 3.67

Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science (2003) 3.59

The habenula: from stress evasion to value-based decision-making. Nat Rev Neurosci (2010) 3.31

How widespread is adult neurogenesis in mammals? Nat Rev Neurosci (2007) 2.87

Adult generation of glutamatergic olfactory bulb interneurons. Nat Neurosci (2009) 2.63

Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol Cell Biol (2005) 2.10

Synaptic memories upside down: bidirectional plasticity at cerebellar parallel fiber-Purkinje cell synapses. Neuron (2006) 2.06

Choroid plexus: biology and pathology. Acta Neuropathol (2009) 1.70

Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice. Proc Natl Acad Sci U S A (2010) 1.69

Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol (2009) 1.24

Distribution of prothymosin alpha in rat tissues. Proc Natl Acad Sci U S A (1984) 1.20

Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol Cell Biol (2000) 1.15

Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ (2008) 1.07

Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone. Neurosci Lett (2006) 1.04

Fifteen years of prothymosin alpha: contradictory past and new horizons. Peptides (2000) 1.03

Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem J (1998) 0.98

"Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol (2009) 0.97

Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay. Biochim Biophys Acta (1996) 0.97

Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. J Virol (2006) 0.96

Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription. EMBO Rep (2002) 0.95

Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc Natl Acad Sci U S A (2010) 0.95

Prothymosin alpha binds to histone H1 in vitro. FEBS Lett (1994) 0.93

Surfing on prothymosin alpha proliferation and anti-apoptotic properties. Neoplasma (2006) 0.92

Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage. Cell Death Differ (2010) 0.88

Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures. J Cell Biol (2007) 0.87

Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signal. FEBS Lett (1997) 0.85

Habenula lesions alter synaptic plasticity within the fimbria-accumbens pathway in the rat. Neuroscience (2006) 0.83

Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation. Proteomics (2007) 0.83

Sensorimotor enhancement in mouse mutants lacking the Purkinje cell-specific Gi/o modulator, Pcp2(L7). Mol Cell Neurosci (2008) 0.83

Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage. Pharmacol Ther (2009) 0.82

Prothymosin alpha is a nonspecific facilitator of nuclear processes: studies of run-on transcription. Protein Expr Purif (2000) 0.81

Mobility within the nucleus and neighboring cytosol is a key feature of prothymosin-alpha. J Histochem Cytochem (2000) 0.80

Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation. J Immunol (1992) 0.80

Prothymosin alpha is a component of a linker histone chaperone. FEBS Lett (2010) 0.79

Function of prothymosin alpha in chromatin decondensation and expression of thymosin beta-4 linked to angiogenesis and synaptic plasticity. Ann N Y Acad Sci (2007) 0.79

Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes. Neurochem Int (2009) 0.79

[Depression and treatment. Apoptosis, neuroplasticity and antidepressants]. Acta Med Port (2006) 0.79

Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.79

Does prothymosin alpha affect the phosphorylation of elongation factor 2? J Biol Chem (1999) 0.77

Prothymosin alpha stimulates Ca2+-dependent phosphorylation of elongation factor 2 in cellular extracts. J Biol Chem (1998) 0.77

Prothymosin alpha 1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients. Int J Immunopharmacol (1997) 0.76

Prothymosin alpha as robustness molecule against ischemic stress to brain and retina. Ann N Y Acad Sci (2010) 0.75

Articles by these authors

(truncated to the top 100)

Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med (2004) 2.71

TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A (2009) 2.20

Dental changes evaluated with a 3D computer-assisted model analysis after long-term tongue retaining device wear in OSA patients. Sleep Breath (2008) 2.02

Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci (2010) 1.31

Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther (2003) 1.30

Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther (2006) 1.24

Oral health, general health, and quality of life in older people. Spec Care Dentist (2008) 1.24

Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J Biol Chem (2009) 1.17

Urban poverty: an urgent public health issue. J Urban Health (2007) 1.14

Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci U S A (2002) 1.14

TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. Cell Calcium (2010) 1.13

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain (2008) 1.13

Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci (2003) 1.12

Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J (2002) 1.12

Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther (2004) 1.11

Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci (2005) 1.07

Olfactory imprinting of amino acids in lacustrine sockeye salmon. PLoS One (2010) 1.00

Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain (2010) 1.00

Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J Pharmacol Exp Ther (2003) 0.99

Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test. Mol Pain (2006) 0.97

Noncompetitive detection of low molecular weight peptides by open sandwich immunoassay. Anal Chem (2007) 0.96

Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res (2002) 0.96

Emerging functions for tuberoinfundibular peptide of 39 residues. Trends Endocrinol Metab (2003) 0.96

"Quenchbodies": quench-based antibody probes that show antigen-dependent fluorescence. J Am Chem Soc (2011) 0.96

Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain (2008) 0.95

Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther (2010) 0.95

Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther (2003) 0.95

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain (2009) 0.95

Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. Biochem Biophys Res Commun (2009) 0.94

Chaperone-assisted folding of a single-chain antibody in a reconstituted translation system. Biochem Biophys Res Commun (2004) 0.94

Nasal pressure recordings to detect obstructive sleep apnea. Sleep Breath (2006) 0.93

LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int (2006) 0.92

NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett (2006) 0.91

The algogenic-induced nociceptive flexion test in mice: studies on sensitivity of the test and stress on animals. Brain Res Bull (2003) 0.91

Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain. Mol Pain (2011) 0.90

Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain (2008) 0.90

Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain (2006) 0.90

Importance of terminal residues on circularly permutated Escherichia coli alkaline phosphatase with high specific activity. J Biosci Bioeng (2005) 0.90

Detection of protein-protein interaction by bioluminescence resonance energy transfer from firefly luciferase to red fluorescent protein. J Biosci Bioeng (2002) 0.89

Possible mechanisms by which adipocyte lipolysis is enhanced in exercise-trained rats. Biochem Biophys Res Commun (2002) 0.89

Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis Rheum (2013) 0.89

Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem (2009) 0.89

Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain. Eur J Neurosci (2002) 0.88

Involvement of LPA1 receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury. Mol Pain (2008) 0.88

Open sandwich-based immuno-transistor for label-free and noncompetitive detection of low molecular weight antigen. Anal Chem (2009) 0.87

Creation of a thermostable firefly luciferase with pH-insensitive luminescent color. Photochem Photobiol (2003) 0.87

In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord. J Pharmacol Exp Ther (2003) 0.87

Gi2 signaling enhances proliferation of neural progenitor cells in the developing brain. J Biol Chem (2004) 0.87

Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport (2009) 0.86

Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin. FEBS J (2008) 0.86

Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. J Neurochem (2010) 0.86

Human IgG1 expression in silkworm larval hemolymph using BmNPV bacmids and its N-linked glycan structure. J Biotechnol (2008) 0.86

Behavioral responses by migratory chum salmon to amino acids in natal stream water. Zoolog Sci (2009) 0.86

EMG telemetry studies on upstream migration of chum salmon in the Toyohira River, Hokkaido, Japan. Fish Physiol Biochem (2011) 0.86

Life with and without heart disease among women and men over 50. J Women Aging (2008) 0.85

Detection of vimentin serine phosphorylation by multicolor Quenchbodies. Biosens Bioelectron (2012) 0.85

Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem (2010) 0.85

Open-sandwich enzyme immunoassay for one-step noncompetitive detection of corticosteroid 11-deoxycortisol. Anal Chem (2009) 0.85

Thoracoscopic esophagectomy and hand-assisted laparoscopic gastric mobilization for esophageal cancer with situs inversus totalis. J Gastrointest Surg (2011) 0.85

Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain. J Neurochem (2008) 0.85

Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia. Neurochem Int (2008) 0.85

Importance of a CDR H3 basal residue in V(H)/V(L) interaction of human antibodies. J Biochem (2002) 0.84

Luminescent and substrate binding activities of firefly luciferase N-terminal domain. Biochim Biophys Acta (2003) 0.84

Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain. Mol Pain (2006) 0.84

Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively. J Pharmacol Exp Ther (2003) 0.84

Central administration of somatostatin stimulates feeding behavior in chicks. Gen Comp Endocrinol (2009) 0.84

Olfactory homing of chum salmon to stable compositions of amino acids in natal stream water. Zoolog Sci (2013) 0.84

An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Mol Pain (2013) 0.84

Voltage-dependent N-type Ca2+ channel activity regulates the interaction between FGF-1 and S100A13 for stress-induced non-vesicular release. Cell Mol Neurobiol (2006) 0.84

Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia. J Neurochem (2008) 0.84

Expression of smooth muscle cell-specific proteins in neural progenitor cells induced by agonists of G protein-coupled receptors and transforming growth factor-beta. J Neurochem (2007) 0.83

Laboratory culture of the Oriental lancelet Branchiostoma belcheri. Zoolog Sci (2007) 0.83

Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments. BMC Biotechnol (2013) 0.83

The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity. FEBS J (2006) 0.83

Rapid homogeneous immunoassay of peptides based on bioluminescence resonance energy transfer from firefly luciferase. J Biosci Bioeng (2002) 0.83

Central administration of leucine, but not isoleucine and valine, stimulates feeding behavior in neonatal chicks. Neurosci Lett (2004) 0.83

The orexigenic effect of GnIH is mediated by central opioid receptors in chicks. Comp Biochem Physiol A Mol Integr Physiol (2008) 0.82

Novel type of Gq/11 protein-coupled neurosteroid receptor sensitive to endocrine disrupting chemicals in mast cell line (RBL-2H3). Br J Pharmacol (2005) 0.82

Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain (2011) 0.82

Seasonal changes of responses to gonadotropin-releasing hormone analog in expression of growth hormone/prolactin/somatolactin genes in the pituitary of masu salmon. Gen Comp Endocrinol (2003) 0.82

Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI. J Med Chem (2010) 0.82

Identification of a Rho family specific guanine nucleotide exchange factor, FLJ00018, as a novel actin-binding protein. Cell Signal (2012) 0.82

Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch. Nucleic Acids Res (2003) 0.82

HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. Br J Pharmacol (2013) 0.82

A homogeneous noncompetitive immunoassay for the detection of small haptens. Anal Chem (2002) 0.81

Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells. J Cell Physiol (2002) 0.81

Kinetics and binding sites for interaction of the prefoldin with a group II chaperonin: contiguous non-native substrate and chaperonin binding sites in the archaeal prefoldin. J Biol Chem (2004) 0.81

Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia. Neurosci Lett (2010) 0.81

Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models. J Pharmacol Sci (2012) 0.81

Endocrine disrupting chemical atrazine causes degranulation through Gq/11 protein-coupled neurosteroid receptor in mast cells. Toxicol Sci (2005) 0.81

Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents. Mol Pain (2007) 0.81

Verification of a specific reaction between an airborne antigen and an immobilized antibody at a gas-solid interface. Anal Sci (2009) 0.81

A large cystic tumor with bile duct communication originating around the hepatic hilum. J Gastrointestin Liver Dis (2010) 0.81

Seasonal changes in CRF-I and urotensin I transcript levels in masu salmon: correlation with cortisol secretion during spawning. Gen Comp Endocrinol (2007) 0.81

Direct construction of an open-sandwich enzyme immunoassay for one-step noncompetitive detection of thyroid hormone T4. Anal Chem (2011) 0.80

Insulin receptor-protein kinase C-gamma signaling mediates inhibition of hypoxia-induced necrosis of cortical neurons. J Pharmacol Exp Ther (2005) 0.80

Exercise training increases membrane bound form of tumor necrosis factor-alpha receptors with decreases in the secretion of soluble forms of receptors in rat adipocytes. Life Sci (2002) 0.80

The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor. J Biochem (2009) 0.80

Detection of small molecule diagnostic markers with phage-based open-sandwich immuno-PCR. J Immunol Methods (2012) 0.80

Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain. Protein Eng Des Sel (2004) 0.80